DRI Healthcare Trust (TSE:DHT.UN) Given Average Recommendation of “Moderate Buy” by Brokerages

Shares of DRI Healthcare Trust (TSE:DHT.UN) have earned an average recommendation of “Moderate Buy” from the six analysts that are covering the company, MarketBeat reports. One research analyst has rated the stock with a hold rating and five have given a buy rating to the company. The average twelve-month price objective among brokers that have covered the stock in the last year is C$18.00.

Several research analysts recently commented on DHT.UN shares. Scotiabank raised their price target on shares of DRI Healthcare Trust from C$21.00 to C$22.00 and gave the company an “outperform” rating in a report on Tuesday, October 8th. Raymond James reduced their target price on shares of DRI Healthcare Trust from C$23.00 to C$22.00 in a report on Wednesday, November 13th.

DRI Healthcare Trust Stock Up 0.6 %

TSE:DHT.UN opened at C$8.70 on Thursday. The firm’s 50 day moving average is C$13.39 and its two-hundred day moving average is C$13.40. DRI Healthcare Trust has a fifty-two week low of C$10.39 and a fifty-two week high of C$17.43.

DRI Healthcare Trust Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, October 18th. Shareholders of record on Friday, October 18th were issued a dividend of $0.085 per share. This represents a $0.34 annualized dividend and a yield of 3.91%. The ex-dividend date was Friday, September 27th. DRI Healthcare Trust’s dividend payout ratio is currently -920.00%.

About DRI Healthcare Trust

DRI Healthcare Trust focuses on managing and growing a portfolio of pharmaceutical royalties. It owns a portfolio of 18 royalties derived from the sale of 14 various pharmaceutical products that focuses on eight therapeutic areas. The company was incorporated in 2020 and is headquartered in Toronto, Canada.